Sources Used in Current Review
(© 1995–2017). Calprotectin, Feces. Mayo Clinic Mayo Medical Laboratories. Available online at https://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/63016. Accessed on 1/22/17.
Rowe, W. and Lichtenstein, G. (2016 June 17 Updated). Inflammatory Bowel Disease Workup. Medscape Drugs and Diseases. Available online at https://emedicine.medscape.com/article/179037-workup#c6. Accessed on 1/22/17.
Walsham, N. and Sherwood, R. (2016 January 28). Fecal calprotectin in inflammatory bowel disease. Clin Exp Gastroenterol. 2016; 9: 21–29. Available online at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734737/ Accessed on 1/22/17.
Douglas, D. (2016 January 04). Fecal Calprotectin Level Not Consistent in IBD. Reuters Health Information. Available online at https://www.medscape.com/viewarticle/856661. Accessed on 1/22/17.
Zhulina, Y. et. al. (2016). The Prognostic Significance of Faecal Calprotectin in Patients With Inactive Inflammatory Bowel Disease. Aliment Pharmacol Ther. 2016;44(5):495-504. Available online at https://www.medscape.com/viewarticle/867381. Accessed on 1/22/17.
(2016 November Updated). Inflammatory Bowel Disease – IBD. ARUP Consult. Available online at https://arupconsult.com/content/inflammatory-bowel-disease. Accessed on 1/22/17.
(November 21, 2015) American Academy of Pediatrics. Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD). Available online at https://www.healthychildren.org/English/health-issues/conditions/abdominal/Pages/Irritable-Bowel-Syndrome-IBS-and-Inflammatory-Bowel-Disease-IBD.aspx. Accessed March 5, 2017.
Sources Used in Previous Reviews
Caccaro, R. et. al. (2012). Clinical Utility of Calprotectin and Lactoferrin in Patients With Inflammatory Bowel Disease. Medscape Today News from Expert Rev Clin Immunol v8 (6):579-585 [On-line information]. Available online at https://www.medscape.com/viewarticle/771596. Accessed February 2013.
Manz, M. et. al. (2012). Value of Fecal Calprotectin in the Evaluation of Patients With Abdominal Discomfort, An Observational Study. Medscape Today News from BMC Gastroenterol. v12 (5) [On-line information]. Available online at https://www.medscape.com/viewarticle/761448 Accessed February 2013.
Henderson, P. et. al. (2012). The Diagnostic Accuracy of Fecal Calprotectin During the Investigation of Suspected Pediatric Inflammatory Bowel Disease. Medscape Today News from Am J Gastroenterol. v107 (6):941-949 [On-line information]. Available online at https://www.medscape.com/viewarticle/766411. Accessed February 2013.
Gundling, F. et. al. (2011). Fecal Calprotectin is a Useful Screening Parameter for Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis in Cirrhosis. Medscape Today News from Liver International v31 (9):1406-1415 [On-line information]. Available online at https://www.medscape.com/viewarticle/757918. Accessed February 2013.
Sherwood, R. (2012). Faecal Markers of Gastrointestinal Inflammation. Medscape Today News from J Clin Pathol. v65 (11):981-985 [On-line information]. Available online at https://www.medscape.com/viewarticle/773411. Accessed February 2013.
Prakash, R. and Mullen, K (2011). Intestinal Inflammation, Key to Complications in Cirrhosis. Medscape Today News from Nat Rev Gastroenterol Hepatol v8 (12):665-667 [On-line information]. Available online at https://www.medscape.com/viewarticle/754868. Accessed February 2013.
Hashash, J. and Regueiro, M. (2012). The Evolving Management of Postoperative Crohn’s Disease. Medscape Today News from Expert Rev Gastroenterol Hepatol v6 (5):637-648 [On-line information]. Available online at https://www.medscape.com/viewarticle/772973. Accessed February 2013.
DuPont, H. (2012). Approach to the Patient With Infectious Colitis. Medscape Today News from Curr Opin Gastroenterol. v28 (1):39-46. [On-line information]. Available online at https://www.medscape.com/viewarticle/755614. Accessed February 2013.
(2011 April 30). Diagnosing and Managing IBD. Crohn’s and Colitis Foundation of America [On-line information]. Available online at https://www.ccfa.org/resources/diagnosing-and-managing-ibd.html. Accessed February 2013.
Tebo, A. (2013 January). Inflammatory Bowel Disease – IBD. ARUP Consult [On-line information]. Available online at https://www.arupconsult.com/Topics/IBD.html?client_ID=LTD. Accessed February 2013.
(© 1995–2013). Calprotectin. Mayo Clinic Mayo Medical Laboratories [On-line information]. Available online at https://www.mayomedicallaboratories.com/test-catalog/Overview/91597 through https://www.mayomedicallaboratories.com. Accessed February 2013.
Juckett, G. (2011 November 15). Evaluation of Chronic Diarrhea. Am Fam Physician. v84 (10):1119-1126. [On-line information]. Available online at https://www.aafp.org/afp/2011/1115/p1119.html. Accessed February 2013.
Wilkins, T. et. al. (2011 December 15). Diagnosis and Management of Crohn’s Disease. Am Fam Physician. v84 (12):1365-1375. [On-line information]. Available online at https://www.aafp.org/afp/2011/1215/p1365.html. Accessed February 2013.
Sidhu, R. et. al. (2010). Faecal Lactoferrin – A Novel Test to Differentiate between the Irritable and Inflamed Bowel? Medscape Today News from Aliment Pharmacol Ther. v31 (12):1365-1370. [On-line information]. Available online at https://www.medscape.com/viewarticle/723031. Accessed February 2013.
Manohara, J. et. al. (2009 January). Fecal Calprotectin and Lactoferrin as Noninvasive Markers of Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition v48 (1): 48-54. [On-line information]. Available online through https://journals.lww.com. Accessed February 2013.